{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:05:04Z","timestamp":1783947904632,"version":"3.55.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jconrel.2023.07.007","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T19:17:08Z","timestamp":1689189428000},"page":"496-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Genome editing mRNA nanotherapies inhibit cervical cancer progression and regulate the immunosuppressive microenvironment for adoptive T-cell therapy"],"prefix":"10.1016","volume":"360","author":[{"given":"Kaijian","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lupin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.07.007_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0010","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/jcp.2004.022863","article-title":"Persistent high risk hpv infection associated with development of cervical neoplasia in a prospective population study","volume":"58","author":"Cuschieri","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0015","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1200\/JCO.2017.74.5471","article-title":"Safety and efficacy of pembrolizumab in advanced, programmed death ligand 1-positive cervical cancer: results from the phase ib keynote-028 trial","volume":"35","author":"Frenel","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0020","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/science.aak9510","article-title":"Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer","volume":"356","author":"Stevanovi\u0107","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0025","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1200\/JCO.2014.58.4391","article-title":"Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: the open-label randomized phase iii trial jcog0505","volume":"33","author":"Kitagawa","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1470-2045(15)70004-5","article-title":"Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (nrg oncology-gynecologic oncology group protocol 240)","volume":"16","author":"Penson","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/annonc\/mdw635","article-title":"A phase i trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an nrg oncology study (nct#01281852)","volume":"28","author":"Thaker","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0040","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41388-017-0083-1","article-title":"Hpv16 e6 and e7 upregulate the histone lysine demethylase kdm2b through the c-myc\/mir-146a-5p axys","volume":"37","author":"Peta","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005854","article-title":"Interaction of the human papillomavirus e6 oncoprotein with sorting nexin 27 modulates endocytic cargo transport pathways","volume":"12","author":"Ganti","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0050","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1158\/1078-0432.CCR-15-2574","article-title":"Cervical cancer stem cells selectively overexpress hpv oncoprotein e6 that controls stemness and self-renewal through upregulation of hes1","volume":"22","author":"Tyagi","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0055","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature16481","article-title":"Structure of the e6\/e6ap\/p53 complex required for hpv-mediated degradation of p53","volume":"529","author":"Martinez-Zapien","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0060","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/0008-5472.CAN-17-2118","article-title":"E6 protein expressed by high-risk hpv activates super-enhancers of the egfr and c-met oncogenes by destabilizing the histone demethylase kdm5c","volume":"78","author":"Chen","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0065","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2017.08.001","article-title":"Hpv16 e7 genetic conservation is critical to carcinogenesis","volume":"170","author":"Mirabello","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0070","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1038\/onc.2013.417","article-title":"P21 suppresses inflammation and tumorigenesis on prb-deficient stratified epithelia","volume":"33","author":"Saiz-Ladera","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0075","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1200\/JCO.2014.58.9093","article-title":"Complete regression of metastatic cervical cancer after treatment with human papillomavirus\u2013targeted tumor-infiltrating t cells","volume":"33","author":"Stevanovi\u0107","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.477","article-title":"Docosahexaenoic acid induces the degradation of hpv e6\/e7 oncoproteins by activating the ubiquitin-proteasome system","volume":"5","author":"Jing","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0085","doi-asserted-by":"crossref","first-page":"E5290","DOI":"10.1073\/pnas.1514418112","article-title":"Unique potential of 4-1bb agonist antibody to promote durable regression of hpv+ tumors when combined with an e6\/e7 peptide vaccine","volume":"112","author":"Bartkowiak","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0090","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(15)00239-1","article-title":"Safety, efficacy, and immunogenicity of vgx-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 e6 and e7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial","volume":"386","author":"Trimble","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0095","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1021\/acs.chemrev.6b00799","article-title":"Crispr\/cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery","volume":"117","author":"Wang","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0100","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMra1800729","article-title":"A new class of medicines through DNA editing","volume":"380","author":"Porteus","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41591-018-0338-6","article-title":"Development of a crispr\/cas9-based therapy for Hutchinson\u2013Gilford progeria syndrome","volume":"25","author":"Santiago-Fern\u00e1ndez","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41591-019-0343-4","article-title":"Single-dose crispr\u2013cas9 therapy extends lifespan of mice with Hutchinson\u2013Gilford progeria syndrome","volume":"25","author":"Beyret","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0120","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-med-081117-010451","article-title":"Crispr correction of duchenne muscular dystrophy","volume":"70","author":"Min","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0125","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/17425247.2020.1747429","article-title":"Delivery of genome editing tools: a promising strategy for hpv-related cervical malignancy therapy","volume":"17","author":"Aghamiri","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0130","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.addr.2020.05.002","article-title":"Delivery of genome-editing biomacromolecules for treatment of lung genetic disorders","volume":"168","author":"Wan","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12951-021-00970-w","article-title":"Crispr\/cas9 nanoeditor of double knockout large fragments of e6 and e7 oncogenes for reversing drugs resistance in cervical cancer","volume":"19","author":"Li","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0140","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.ymthe.2019.08.012","article-title":"Systemic delivery of crispr\/cas9 targeting hpv oncogenes is effective at eliminating established tumors","volume":"27","author":"Jubair","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0145","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.ymthe.2018.07.019","article-title":"Nanoparticles based on poly (\u03b2-amino ester) and hpv16-targeting crispr\/shrna as potential drugs for hpv16-related cervical malignancy","volume":"26","author":"Zhu","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0150","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jconrel.2020.02.045","article-title":"Hyperbranched poly(beta-amino ester) based polyplex nanopaticles for delivery of crispr\/cas9 system and treatment of hpv infection associated cervical cancer","volume":"321","author":"Gao","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0155","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1038\/s41598-017-05696-0","article-title":"Talen based hpv-e7 editing triggers necrotic cell death in cervical cancer cells","volume":"7","author":"Shankar","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0160","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/aps.2017.2","article-title":"Therapeutic gene editing: delivery and regulatory perspectives","volume":"38","author":"Shim","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0165","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jconrel.2022.02.012","article-title":"A targeting delivery system for effective genome editing in leukemia cells to reverse malignancy","volume":"343","author":"Ren","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0170","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jconrel.2021.06.030","article-title":"In vivo targeted delivery of nucleic acids and crispr genome editors enabled by gsh-responsive silica nanoparticles","volume":"336","author":"Wang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0175","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020401118","article-title":"Lipid nanoparticle-mediated codelivery of cas9 mrna and single-guide rna achieves liver-specific in vivo genome editing of angptl3","volume":"118","author":"Qiu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0180","doi-asserted-by":"crossref","first-page":"1902575","DOI":"10.1002\/adma.201902575","article-title":"Fast and efficient crispr\/cas9 genome editing in vivo enabled by bioreducible lipid and messenger rna nanoparticles","volume":"31","author":"Liu","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119302","article-title":"In situ repurposing of dendritic cells with crispr\/cas9-based nanomedicine to induce transplant tolerance","volume":"217","author":"Zhang","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0190","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1038\/s41467-018-06522-5","article-title":"Targeting of nlrp3 inflammasome with gene editing for the amelioration of inflammatory diseases","volume":"9","author":"Xu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0195","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt.3471","article-title":"Therapeutic genome editing by combined viral and non-viral delivery of crispr system components in vivo","volume":"34","author":"Yin","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0200","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mattod.2018.12.003","article-title":"Material solutions for delivery of crispr\/cas-based genome editing tools: current status and future outlook","volume":"26","author":"Wan","year":"2019","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0205","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1021\/acs.accounts.8b00493","article-title":"Integrating combinatorial lipid nanoparticle and chemically modified protein for intracellular delivery and genome editing","volume":"52","author":"Chang","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0210","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1158\/2326-6066.CIR-19-0315","article-title":"Myeloid cells orchestrate systemic immunosuppression, impairing the efficacy of immunotherapy against hpv+ cancers","volume":"8","author":"Galliverti","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0215","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41392-020-00419-w","article-title":"Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy","volume":"6","author":"Bhat","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0220","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1128\/JVI.01879-14","article-title":"Inactivation of the human papillomavirus e6 or e7 gene in cervical carcinoma cells by using a bacterial crispr\/cas rna-guided endonuclease","volume":"88","author":"Kennedy","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biomaterials.2017.07.035","article-title":"Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis","volume":"143","author":"Dou","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0230","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jconrel.2016.01.043","article-title":"Nanomaterial-dependent immunoregulation of dendritic cells and its effects on biological activities of contraceptive nanovaccines","volume":"225","author":"Xu","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0235","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.biomaterials.2016.08.003","article-title":"Nanoparticles responsive to the inflammatory microenvironment for targeted treatment of arterial restenosis","volume":"105","author":"Feng","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0240","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1016\/j.biomaterials.2014.02.009","article-title":"Inhibition of hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by a mtor sirna-loaded cyclodextrin nanovector","volume":"35","author":"Liu","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0245","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1002\/adma.201100679","article-title":"Facile engineering of biocompatible materials with ph-modulated degradability","volume":"23","author":"Zhang","year":"2011","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0250","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nrm883","article-title":"Signal transduction and endocytosis: close encounters of many kinds","volume":"3","author":"Sorkin","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0255","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jconrel.2020.09.008","article-title":"Bioresponsive drug delivery systems for the treatment of inflammatory diseases","volume":"327","author":"Dou","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0260","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1016\/j.biomaterials.2013.02.035","article-title":"A ph-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector for gene delivery","volume":"34","author":"Chen","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0265","doi-asserted-by":"crossref","first-page":"2002131","DOI":"10.1002\/adfm.202002131","article-title":"Site-specific microrna-33 antagonism by ph-responsive nanotherapies for treatment of atherosclerosis via regulating cholesterol efflux and adaptive immunity","volume":"30","author":"Li","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0270","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","article-title":"A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine","volume":"92","author":"Boussif","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0275","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0169-409X(01)00230-7","article-title":"Cyclodextrins in oligonucleotide delivery","volume":"53","author":"Redenti","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0280","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10529-016-2064-9","article-title":"Improved delivery of cas9 protein\/grna complexes using lipofectamine crisprmax","volume":"38","author":"Yu","year":"2016","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0285","first-page":"1981","article-title":"Safety and efficiency of crispr-cas9 gene editing in the retinal pigment epithelium","volume":"58","author":"Kleinman","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0290","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/acsnano.6b04261","article-title":"Artificial virus delivers crispr-cas9 system for genome editing of cells in mice","volume":"11","author":"Li","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0295","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0300","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.bbabio.2010.03.026","article-title":"Cationic carriers of genetic material and cell death: a mitochondrial tale","volume":"1797","author":"Hunter","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0305","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1124\/jpet.107.136077","article-title":"Dependence of reactive oxygen species and flice inhibitory protein on lipofectamine-induced apoptosis in human lung epithelial cells","volume":"325","author":"Kongkaneramit","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0310","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1038\/sj.onc.1209429","article-title":"Inhibition of bax activity is crucial for the antiapoptotic function of the human papillomavirus e6 oncoprotein","volume":"25","author":"Vogt","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0315","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1128\/JVI.78.8.4063-4073.2004","article-title":"Repression of the human papillomavirus e6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in hela cervical carcinoma cells","volume":"78","author":"Horner","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0320","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/carcin\/bgr192","article-title":"Withaferin a induces p53-dependent apoptosis by repression of hpv oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells","volume":"32","author":"Munagala","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0325","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-021-00669-3","article-title":"The use of new crispr tools in cardiovascular research and medicine","volume":"19","author":"Nishiga","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0330","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.addr.2020.02.003","article-title":"Therapeutic genome editing in cardiovascular diseases","volume":"168","author":"Nishiga","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0335","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/bjc.1998.143","article-title":"The retinoblastoma protein-associated cell cycle arrest in s-phase under moderate hypoxia is disrupted in cells expressing hpv18 e7 oncoprotein","volume":"77","author":"Amellem","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0340","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4143\/crt.2005.37.6.319","article-title":"The role of hpv e6 and e7 oncoproteins in hpv-associated cervical carcinogenesis","volume":"37","author":"Yim","year":"2005","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0345","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2004.02.022","article-title":"Hpv18 e6 and e7 genes affect cell cycle, prb and p53 of cervical tumor cells and represent prominent candidates for intervention by use peptide nucleic acids (pnas)","volume":"209","author":"Braun","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0350","doi-asserted-by":"crossref","first-page":"10559","DOI":"10.1128\/JVI.76.20.10559-10568.2002","article-title":"Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 e7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells","volume":"76","author":"Helt","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0355","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1158\/1078-0432.CCR-07-1880","article-title":"Induction of tumor-specific cd4+ and cd8+ t-cell immunity in cervical cancer patients by a human papillomavirus type 16 e6 and e7 long peptides vaccine","volume":"14","author":"Welters","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0360","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41587-022-01245-x","article-title":"Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of car-t cells","volume":"40","author":"Agarwalla","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0365","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nbt.3461","article-title":"Inclusion of strep-tag ii in design of antigen receptors for t-cell immunotherapy","volume":"34","author":"Liu","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0370","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/86523","article-title":"Therapy of human tumors in nod\/scid mice with patient-derived reactivated memory t cells from bone marrow","volume":"7","author":"Feuerer","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0375","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41586-019-0985-x","article-title":"Nr4a transcription factors limit car t cell function in solid tumours","volume":"567","author":"Chen","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0380","doi-asserted-by":"crossref","first-page":"2209466","DOI":"10.1002\/adfm.202209466","article-title":"Stem cell-niche engineering via multifunctional hydrogel potentiates stem cell therapies for inflammatory bone loss","volume":"33","author":"Li","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0385","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41586-022-04585-5","article-title":"Car t cell killing requires the ifn\u03b3r pathway in solid but not liquid tumours","volume":"604","author":"Larson","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0390","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic car t cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0395","doi-asserted-by":"crossref","first-page":"eaay1063","DOI":"10.1126\/scitranslmed.aay1063","article-title":"Sirna nanoparticles targeting camkii\u03b3 in lesional macrophages improve atherosclerotic plaque stability in mice","volume":"12","author":"Tao","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0400","doi-asserted-by":"crossref","first-page":"eaaw1565","DOI":"10.1126\/scitranslmed.aaw1565","article-title":"Synthetic mrna nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mtor inhibition","volume":"11","author":"Kong","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0405","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1021\/acsnano.9b01696","article-title":"Nanobuffering of ph-responsive polymers: a known but sometimes overlooked phenomenon and its biological applications","volume":"13","author":"Tao","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0410","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.4161\/cc.6.16.4555","article-title":"E6\/e7 of hpv type 16 promotes cell invasion and metastasis of human breast cancer cells","volume":"6","author":"Yasmeen","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jconrel.2023.07.007_bb0415","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ijrobp.2016.03.001","article-title":"High e6 gene expression predicts for distant metastasis and poor survival in patients with hpv-positive oropharyngeal squamous cell carcinoma","volume":"95","author":"Khwaja","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0420","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.tibtech.2018.08.010","article-title":"Non-viral delivery to enable genome editing","volume":"37","author":"Rui","year":"2019","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0425","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd.2016.280","article-title":"Delivery technologies for genome editing","volume":"16","author":"Yin","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2023.07.007_bb0430","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3776","article-title":"Association of ipilimumab with safety and antitumor activity in women with metastatic or recurrent human papillomavirus-related cervical carcinoma","volume":"4","author":"Lheureux","year":"2018","journal-title":"JAMA Oncol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923004315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923004315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:50:21Z","timestamp":1759164621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923004315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":86,"alternative-id":["S0168365923004315"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.007","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genome editing mRNA nanotherapies inhibit cervical cancer progression and regulate the immunosuppressive microenvironment for adoptive T-cell therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}